Format

Send to

Choose Destination
Indian J Cancer. 2018 Jan-Mar;55(1):98-104. doi: 10.4103/ijc.IJC_503_17.

Prognostic factors in parotid cancers: Clinicopathological and treatment factors influencing outcomes.

Author information

1
Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
2
Department of Radiotherapy, Tata Memorial Hospital, Mumbai, Maharashtra, India.

Abstract

Background:

Parotid cancers are uncommon and have a relatively long natural history. Determination of prognostic factors affecting the outcome is difficult.

Materials and Methods:

The primary objective was to determine the demographic, clinical, histopathology and treatment-related factors affecting overall survival (OS) in parotid cancers. The secondary objective was to study the impact of these factors on disease-free survival (DFS) and patterns of failure. Data of consecutive patients who underwent parotidectomy for primary parotid malignancy between July 2006 and April 2015 with at least 6 months of posttreatment follow-up were retrospectively retrieved. Patients whose follow-up status was known at the time of analysis were included. One hundred and sixty-five patients met the inclusion criteria.

Results:

The median follow-up was 38 months. The mean OS and DFS were 141.03 and 124.38 months, respectively. Age > 45 years affected both OS and DFS (P = 0.00 and 0.002 respectively) adversely. Advanced T stage affected adversely OS in univariate (P = 0.00) but not in multivariate analysis (P = 0.91) and DFS in both univariate (P = 0.00) and multivariate analysis (P = 0.005). Nodal positivity adversely affected survival adversely in univariate (P = 0.00 for OS and DFS) and multivariate analysis (P = 0.022 for OS and P = 0.001 for DFS). Resection margin of < 5mm affected OS as compared to a margin of ≥5mm (P = 0.03).

Conclusions:

Nodal positivity is the single most important factor affecting survival in parotid cancers. A histopathological resection margin of at least 5 mm is desirable. Advanced age along with high grade, advanced T and N stages need to be considered for adjuvant treatment.

KEYWORDS:

Lymphatic metastasis; parotid cancers; parotid neoplasms; prognostic factors; retrospective studies; risk assessment; survival analysis

PMID:
30147103
DOI:
10.4103/ijc.IJC_503_17
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd
Loading ...
Support Center